 
            IndraLab
Statements
CYLD activates (-)-noscapine. 15 / 15
                        
    
      
      
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
      
      
        |
        
      
      
        
      
        
      
        
          
          15
          
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
      
    
  
                      
                    
                                      reach
                                
                                  
                                
                                
          
          
                                  "To understand how CYLD modulates noscapine activity in leukemia cells, we transfected cells with GFP, GFP-CYLD, GFP-CYLD-DeltaCG1, in which the extreme N-terminal CAP-Gly domain of CYLD was deleted, or GFP-CYLD-C/S, in which cysteine 601 was mutated to serine to disrupt the deubiquitinase activity of CYLD."